Aspyra Financial Statements From 2010 to 2025
| APYI Stock | USD 0.0002 0.00 0.00% |
Check Aspyra financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Aspyra's main balance sheet or income statement drivers, such as , as well as many indicators such as . Aspyra financial statements analysis is a perfect complement when working with Aspyra Valuation or Volatility modules.
Aspyra |
Aspyra Inc Company Current Valuation Analysis
Aspyra's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current Aspyra Current Valuation | 24.69 K |
Most of Aspyra's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Aspyra Inc is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
| Competition |
In accordance with the recently published financial statements, Aspyra Inc has a Current Valuation of 24.69 K. This is 100.0% lower than that of the Health Care Technology sector and significantly higher than that of the Health Care industry. The current valuation for all United States stocks is 100.0% higher than that of the company.
Aspyra Inc Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Aspyra's current stock value. Our valuation model uses many indicators to compare Aspyra value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Aspyra competition to find correlations between indicators driving Aspyra's intrinsic value. More Info.Aspyra Inc is number one stock in return on equity category among its peers. It is rated fifth in return on asset category among its peers . Comparative valuation analysis is a catch-all model that can be used if you cannot value Aspyra by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Aspyra's Pink Sheet. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.About Aspyra Financial Statements
Investors use fundamental indicators, such as Aspyra's revenue or net income, to determine how well the company is positioned to perform in the future. Although Aspyra's investors may analyze each financial statement separately, they are all interrelated. Understanding these patterns can help investors make the right trading decisions.
Aspyra Inc. provides health care products and services for the laboratory and imaging marketplaces. Aspyra Inc. was founded in 1978 and is headquartered in Jacksonville, Florida. ASPYRA INC operates under Health Information Services classification in the United States and is traded on OTC Exchange. It employs 69 people.
Currently Active Assets on Macroaxis
| DD | Dupont De Nemours | |
| CRDO | Credo Technology Group | |
| GOOG | Alphabet Inc Class C | |
| BAC | Bank of America | |
| CRM | Salesforce |
Other Information on Investing in Aspyra Pink Sheet
Aspyra financial ratios help investors to determine whether Aspyra Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Aspyra with respect to the benefits of owning Aspyra security.